Sexual health

PT-141 (Bremelanotide)

Rx · Prescription onlyInjected under the skin

PT-141

Bremelanotide

On-demand desire boost.

Your plan

$159/mo, $954 billed once for 6 months/mo

$954 billed once for 6 months · unused months refunded on a medical stop

No membership fee · this is the full price · free shipping · avg 4-week supply

Get started
  • Medication, clinician care and dose adjustments, all in one price.
  • ~28-day supply. Your clinician sets your exact dose, so yours may vary; your refill arrives as you finish the last one.

A licensed clinician on our care team reviews every request and prescribes only when it's clinically appropriate.

FDA status: Compounded medication, not FDA-approved.

What it's for

Who it's for

Adults whose problem is desire, not blood flow.

How it's different

It acts on desire in the brain. FDA-approved, as Vyleesi, for premenopausal women.

How it works

PT-141 (bremelanotide) is a melanocortin receptor agonist that increases sexual interest and arousal by activating receptors in the brain and body. It is FDA-approved as Vyleesi for women with hypoactive sexual desire disorder (HSDD). It is used off-label in men with low desire. Given as a subcutaneous injection 2–4 hours before sexual activity, PT-141 does not require daily dosing. Common side effect: nausea in the first hours (30–50% of users), often mild but sometimes requiring an antiemetic.

How to use it and what arrives

1 vial · lasts 4 weeks

2 mg/mL · 5 mL vial

How
Injected under the skin
How often
Once a day

Good to know

Nausea and flushing are common with the first doses. No more than one dose in 24 hours.

What the research shows

PT-141, also called bremelanotide, acts on the desire pathway in the brain. Its one labeled use is for premenopausal women with low desire. The evidence in men is small and early.

  1. Women's desire

    0.30 and 0.42 points

    Two identical 24-week trials in 1,267 premenopausal women with low desire, using bremelanotide 1.75 mg as needed against placebo. Desire rose 0.30 points more than placebo in one trial and 0.42 in the other. The effects are small.

    Kingsberg et al., Obstetrics and Gynecology 2019
  2. Men, nasal

    small early study

    Diamond et al. tested intranasal PT-141 in healthy men and in men with mild-to-moderate erectile dysfunction, measuring erections with RigiScan. It was a small early safety, pharmacokinetic and pharmacodynamic study, not a phase 3 trial.

    Diamond et al., International Journal of Impotence Research 2004
  3. Men, under the skin

    no trial in men

    We found no published phase 3 trial of PT-141 for erectile dysfunction in men. The product sold here is 0.2 mg per dose, a lower dose than the 1.75 mg studied in women, and it has no trial of its own.

    PubMed search, bremelanotide and erectile dysfunction (2026)

Trial figures are for bremelanotide 1.75 mg given under the skin in women. The PT-141 dispensed here is 0.2 mg per dose, a different dose with no trial of its own. Nausea, flushing, headache and vomiting were common in the women's trials.

What this does not say

  • The women's trial effects are modest, and they are averages across groups.
  • No human trial supports the 0.2 mg dose sold here.
  • The label warns that the drug transiently raises blood pressure; the prescriber checks cardiovascular history before any prescription.

Sources

  1. Bremelanotide for hypoactive sexual desire disorder in women: a randomized, placebo-controlled trial. Obstet Gynecol, 2018

Safety

FDA status: Compounded medication, not FDA-approved.

Side effects and precautions

  • PT-141 activates melanocortin receptors in the brain and body.
  • In men, priapism (erection lasting >4 hours) is rare but requires immediate care.

Get care right away

  • Stop and seek care for severe headache, chest pain, priapism, severe nausea, or signs of allergic reaction.

When it isn't prescribed

  • Nausea is common (30–50%), usually mild; do not use with uncontrolled high blood pressure, recent MI, unstable angina, or severe heart disease.

Tell your clinician about blood pressure medications, heart history, and any skin concerns.

Questions

How do I use PT-141?

Inject subcutaneously 2–4 hours before anticipated sexual activity. Effects peak around 1–2 hours after injection and last several hours. One dose per 24 hours maximum. If nausea occurs, taking an anti-nausea medication (like ondansetron) 30 minutes before PT-141 helps some people. Eat a light meal beforehand; a full meal can delay effects.

How long until I see results?

PT-141: sexual effects appear within 1–2 hours of injection, peak around 2 hours, last several hours. Results require dosing each time you want the effect.

What if I have side effects?

PT-141: nausea is common (30–50%); anti-nausea medication beforehand helps. Rare: priapism in men (erection >4 hours)—seek emergency care. Stop immediately if any severe reaction occurs.

Can I use these with other medications?

Tell your clinician about all medications, especially blood pressure drugs or cardiac medications. Some combinations need monitoring.

How long do I use these?

PT-141: as-needed indefinitely, or until your sexual health goals change. Annual check-ins with your clinician are recommended.

Still have a question? Message our team

Ready to start with PT-141?

$159/mo · $954 billed once for 6 months

Get started
  • Free shipping on every order
  • No membership fee
  • Same price at every dose
  • HSA and FSA accepted

More options in this area